Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation

BACKGROUND: The endgame for polio eradication involves coordinated global cessation of oral poliovirus vaccine (OPV) with cessation of serotype 2 OPV (OPV2 cessation) implemented in late April and early May 2016 and cessation of serotypes 1 and 3 OPV (OPV13 cessation) currently planned for after 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Duintjer Tebbens, Radboud J., Hampton, Lee M., Thompson, Kimberly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880825/
https://www.ncbi.nlm.nih.gov/pubmed/27230071
http://dx.doi.org/10.1186/s12879-016-1536-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880825/
https://www.ncbi.nlm.nih.gov/pubmed/27230071
http://dx.doi.org/10.1186/s12879-016-1536-9

Ejemplares similares